Industry News
CBio bucks trend, achieves 'satisfactory' capital raising
Brisbane biotech CBio is set to conclude an 11-month, $5 million capital raising that coincided with the worst investor environment in a decade. [ + ]
Diatranz denies trans-Tasman plans
A New Zealand company working on a pig-derived cure for type 1 diabetes has denied reports of a planned move to Australia. [ + ]
New Australian group in kidney bioengineering push
A consortium of Australia's top kidney scientists has come together with the ambitious goal of using stem cells to engineer a bioartificial organ. [ + ]
New director for Ventracor
Artificial heart device developer Ventracor has appointed a new director to its ranks. [ + ]
Red tape hampering Sirtex at home
The US is embracing Sirtex Medical's novel anti-cancer technology more quickly than Australia where government evaluation of the technology appears to have stalled. [ + ]
Developing nanosensors for astronauts
Along with space suits, freeze-dried food and barf bags, tomorrow's astronauts may travel with nanomolecular devices inside their white blood cells to detect early signs of damage from dangerous radiation or infection.
[ + ]Circadian appoints all-rounder to board
Australian biomedical research developer Circadian Technologies has appointed an accountant with a diverse business background to its board. [ + ]
Peptech looks towards positive second half result in shareholder address
Sydney company Peptech is hinging its hopes for a positive second half result on the issuing of US patents for its anti tumour nectrotising factor. [ + ]
BresaGen revamps board ahead of strategy refocus
A board reshuffle aimed at sharpening the focus of Adelaide biotherapy company BresaGen is underway. The company has announced the resignations of three board members and the appointment of an existing director to the chairman's position. [ + ]
Interpret GM polls with caution: NZ academic
Polls claiming to illustrate community views on genetic modification should be interpreted with caution because they did not always take into account a person's knowledge of the topic, a New Zealand academic has warned. [ + ]
Genesis R&D to study plant hormones
New Zealand based Genesis Research and Development Corporation will get $NZ6 million from the Foundation for Research Science and Technology to discover and investigate new plant hormones and signalling processes. [ + ]
Qld teams with US researchers in drought crop project
Collaborative agreements between researchers at the Queensland Department of Primary Industries and three major US universities - Texas A&M University, Texas Tech and the University of Missouri - could lead to development of drought resistant crops. [ + ]
Get planning, physics head tells synchrotron users
Potential users of Australia's national synchrotron need to start planning now, according to Sir Peter Williams, president of the UK Institute of Physics and proponent of the synchrotron project. [ + ]
ResMed shrugs off a nervous market
Despite being regarded as one of Australia's top three listed biotech stocks, sleep disorder specialist ResMed would probably rather forget 2002. [ + ]
Research identifies enzyme involved in fat storage
Howard Hughes Medical Institute researchers pursuing the cause of leptin's ability to boost metabolism and shed fat have identified a metabolic switch that appears to tell the body to store or burn fat.
[ + ]